ACT

What ACT does

ACT (Arian Chimia Tech Industrial Group, ticker کیمیاتک) is an Iranian publicly-listed manufacturer of cosmetics, pharmaceutical, and personal care products founded in 2003. The company operates the largest cosmetics and health-product manufacturing facility in Iran at 44,000 square meters in the Salfechegan Special Economic Zone, with production lines certified to GMP (Iran Ministry of Health), ISO 22716 (DQS Germany), AEO (Iran Customs), and JAKIM Malaysia Halal standards. Its portfolio comprises nine brands organized across price tiers and use cases: proprietary mass-market brands My, Schon, Callista, Mamababy, and My Pharma; the clinical dermatology brand Neuderm; and exclusively licensed international brands Ellaro (Vignaud Laboratories, France), Newtis (Larouche Laboratories, Canada), and Note (Turkey, held since 2014).

The company's revenue model is product-driven B2C and B2B2C, monetizing through domestic retail-chain distribution, capillary direct sales, branded representatives, owned online storefronts, and international export to 14+ countries. ACT supplements its core cosmetics manufacturing with three wholly-owned subsidiaries: Avinco (chemicals and plastic packaging), Azma Nano (nano systems technology), and Atrin Tejarat Rayehe Afarin (fragrance trading). Corporate governance includes formal board committees (audit, appointments, risk), audited financial statements, and recognized corporate transparency (ranked top 10 in Iran among 560+ companies at the 4th Transparency Trophy, 2025). In 2024 the company raised its registered capital 66.7% to 10,000 billion Rials to fund expansion and reduce bank-financing dependency.

Customer segmentation is horizontal across mass consumers, mother-and-baby, clinical/dermatology, and Halal-conscious consumers in Iran and Muslim-majority export markets. Distribution is multi-channel and includes capillary field sales, retail chain placement, online channels, and international distributor networks. The company is led by CEO Nasser Gorabi and Board Chairman Seyyed Mohammad Bagher Fadelian, with 76% shareholder attendance recorded at the 2024 EGM that approved the capital increase.

Name

ACT

Legal name

Arian Chimia Tech Industrial Group (آریان کیمیا تک)

Website

https://actholding.ir

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ACT (Arian Chimia Tech Industrial Group) is an Iranian publicly-listed manufacturer of cosmetics, pharmaceutical, and personal care products operating the country's largest cosmetics production facility (44,000 sqm). It markets nine proprietary and licensed brands domestically and exports to 14+ countries.

Ownership category

akta.pro rank

Product category

Cosmetics & Personal Care Manufacturing

NAICS

Soap and Cleaning Compound Manufacturing (32561), Soap and Other Detergent Manufacturing (325611)

SIC

Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Hand & Body Care (Lotions, Creams, Body Oils) (CRADANAC)

akta.pro secondary industry

Hand Sanitizers & Antibacterial Personal Care (CRADANAI)

Keywords

• Cosmetics manufacturing
• Pharmaceutical production
• Personal care products
• Health and beauty goods
• Skincare manufacturing

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Product Sales (Domestic): Manufacture and sale of cosmetic, pharmaceutical, and personal care products under owned brands (My, Schon, Neuderm, Callista, Mamababy, My Pharma, Newtis) to domestic Iranian consumers via retail chains, direct sales, and online channels.
2. Product Sales (Export): Export of products to over 14 countries. Also holds exclusive distribution rights for Note brand in Iran since 2014, distributing internationally sourced products alongside own-brand exports.
3. Licensed Brand Distribution: Exclusive distribution of internationally licensed brands in Iran — Note brand (Turkey origin, distributed since 2014), Newtis (under license from Larouche Laboratories, Canada), and Ellaro (under license from Vignaud Laboratories, France).

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

ACT is an Iranian industrial group that manufactures and distributes pharmaceutical, cosmetics, and personal care products across multiple consumer brands. The company operates the largest dedicated cosmetics and health manufacturing facility in Iran (44,000 sqm) located in the Salfechegan Special Economic Zone, producing nine branded product lines for domestic consumption and export to more than 14 countries.

Product overview

ACT (Arian Chimia Tech Industrial Group) is a major Iranian pharmaceutical, cosmetics, and hygiene products manufacturer operating from the Salfachgan Special Economic Zone. The company's product portfolio is organized as a multi-brand strategy comprising both proprietary and licensed brands. Core proprietary brands include My (personal care and fragrance), Schon (herbal skincare), Neuderm (professional dermatology), Callista (color cosmetics), MamaBaby (infant care), and My Pharma (pharmaceutical products). Licensed international brands include Ellaro (French dermocosmetics), NewTIS (Canadian skincare under Larouche license), and Note (Turkish multinational cosmetics with exclusive Iranian distribution since 2014). The company operates the largest cosmetics factory in the Middle East at 44,000 square meters, producing products meeting GMP and ISO 22716 standards for domestic consumption and export to over 14 countries.

Differentiator

Problem solved

Functional benefit

Brands

• My (مای): Primary brand offering health, skin care, hair care, cosmetics, and perfume products. Established in 2003 with international quality standards including GMP and ISO 22716.
• Ellaro (الارو)
• Schon (شون)
• Neuderm (نئودرم)
• Callista (کالیستا)
• MamaBaby (مامابیبی)
• My Pharma (مای فارما)
• Newtis (نیوتیس)
• Note (نوت)

Products and services

• My
• Schon
• Neuderm
• Callista
• MamaBaby
• My Pharma
• NewTis
• Note
• Ellaro

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered major, core and minor.

• Note (Nots Cosmetics)majorChannel Partner/ Reseller/ Distributor · 1 January 2014ACT has held the exclusive distribution rights for Note brand (a multinational cosmetics brand headquartered in Turkey's free trade zone) in Iran since 2014. Note products are manufactured in Altona, Turkey, and some items such as pencils in EU countries. Note exports to over 50 countries worldwide.
• Larouche Laboratories (Canada)coreOEM/ Whitelabel/ Licensing PartnerNewtis health products are manufactured under license from Larouche Laboratories of Canada. ACT produces and distributes Newtis products in Iran using formulations licensed from this Canadian partner, with modern formulations and quality raw materials.
• Vignaud Laboratories (France) — Ellaro BrandcoreOEM/ Whitelabel/ Licensing PartnerEllaro was created by Vignaud Laboratories in France (born January 2007 in Angers). ACT holds the exclusive license to produce and distribute Ellaro products in Iran. The brand draws on European dermatology and skin care research, with production lines also in Canada and Switzerland.
• JAKIM Malaysia (Department of Islamic Development Malaysia)majorOthersJAKIM Malaysia is the international certifying body that issued Halal certification to ACT for its cosmetic and health products — the first such certification for Iran's cosmetics industry. JAKIM standards are recognized by Muslim-majority countries including Indonesia, Saudi Arabia, UAE, Turkey, and Pakistan.
• Doust Autism Charity (Mozayeran Doust Autism)minorOthersACT brands My, Schon, and Calista participated in a CSR event co-organized with Doust Autism Charity at a Yalda evening celebration for individuals with autism and their families.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Golrang Industrial Group: Iran's largest domestic producer of hygiene, personal care and household products (brands like Golrang, Avish, Pentamed). Operates a multi-brand house with national manufacturing footprint, making it the most direct like-for-like competitor to ACT inside Iran.

Broad incumbents

• Amorepacific: South Korean beauty conglomerate spanning mass (Laneige, Innisfree, Etude) to luxury (Sulwhasoo). Comparable for its multi-brand house strategy, color cosmetics depth, and strong export-driven growth model — a structural analogue to ACT's strategy.
• Beiersdorf: German multinational behind Nivea, Eucerin and La Prairie. Comparable via its clinical/dermatological skincare positioning (mirroring Neuderm) and its scale-based mass personal care business spanning body, hand and face care globally.
• LG Household & Health Care: Korean personal care and home care company behind The History of Whoo, Su:m37°, and household brands. Comparable in its dual cosmetic + household product manufacturing model and Asian cross-border distribution expertise.
• Unilever Beauty & Wellbeing: Unilever's personal care division (Dove, Rexona, Vaseline, Lux, Sunsilk). Most comparable in mass-market body care, hand hygiene and personal wash categories where ACT's My and Schon brands compete.
• Coty: US-listed global beauty company (CoverGirl, Max Factor, Hugo Boss fragrances, Kylie Cosmetics). Relevant peer for color cosmetics (Callista), fragrance and licensed brand distribution similar to ACT's Note and Ellaro arrangements.
• Henkel: German multinational with consumer beauty (Schwarzkopf, Fa, Syoss) and adhesive/personal care portfolios. Relevant on haircare, body care and beauty retail channels analogous to several ACT sub-brands.
• L'Oréal: World's largest cosmetics group with active skincare, haircare, fragrance and dermatological brands (L'Oréal Paris, Garnier, La Roche-Posay, CeraVe). Comparable across ACT's entire nine-brand portfolio of mass, clinical, color cosmetics and fragrance categories.

Regional players

• IFFCO Group: UAE-based conglomerate with significant FMCG, personal care and food operations serving Middle East, Africa and Asia. Comparable as a regional Halal-conscious CPG manufacturer with multi-country distribution reach similar to ACT's 14+ country export footprint.

Emerging players

• Dabur India: Large Indian Ayurvedic and natural personal care conglomerate (Dabur, Vatika, Fem). Comparable in its plant-based and natural-extract positioning — similar to ACT's Schon herbal brand — and its emerging-market distribution playbook.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/actholding
• LinkedInlinkedin.com/company/arian-chimia-tech

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACT